CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease

por Wendt, Emily, Keshav, Satish
Publicado 2015

Ratiometric Analysis of Fura Red by Flow Cytometry: A Technique for Monitoring Intracellular Calcium Flux in Primary Cell Subsets

por Wendt, Emily R., Ferry, Helen, Greaves, David R., Keshav, Satish
Publicado 2015

Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate...

por Sandborn, William J, Bhandari, Bal R, Randall, Charles, Younes, Ziad H, Romanczyk, Tomasz, Xin, Yan, Wendt, Emily, Chai, Hao, McKevitt, Matt, Zhao, Sally, Sundy, John S, Keshav, Satish, Danese, Silvio
Publicado 2018

A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s Disease

por Schreiber, Stefan, Siegel, Corey A, Friedenberg, Keith A, Younes, Ziad H, Seidler, Ursula, Bhandari, Bal R, Wang, Ke, Wendt, Emily, McKevitt, Matt, Zhao, Sally, Sundy, John S, Lee, Scott D, Loftus, Edward V
Publicado 2018

Circulating and Tissue-Resident CD4(+) T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation

por Hegazy, Ahmed N., West, Nathaniel R., Stubbington, Michael J.T., Wendt, Emily, Suijker, Kim I.M., Datsi, Angeliki, This, Sebastien, Danne, Camille, Campion, Suzanne, Duncan, Sylvia H., Owens, Benjamin M.J., Uhlig, Holm H., McMichael, Andrew, Bergthaler, Andreas, Teichmann, Sarah A., Keshav, Satish, Powrie, Fiona
Publicado 2017